Mirko Arcuri

644 total citations
7 papers, 432 citations indexed

About

Mirko Arcuri is a scholar working on Molecular Biology, Virology and Epidemiology. According to data from OpenAlex, Mirko Arcuri has authored 7 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Mirko Arcuri's work include HIV Research and Treatment (3 papers), Microfluidic and Bio-sensing Technologies (2 papers) and Hepatitis B Virus Studies (2 papers). Mirko Arcuri is often cited by papers focused on HIV Research and Treatment (3 papers), Microfluidic and Bio-sensing Technologies (2 papers) and Hepatitis B Virus Studies (2 papers). Mirko Arcuri collaborates with scholars based in Italy, United States and Germany. Mirko Arcuri's co-authors include Elena Fattori, Alfredo Nicosia, Alessandra Vitelli, Annalisa Meola, Elisabetta Sporeno, Stefano Colloca, Antonella Folgori, Bruno Bruni Ercole, Alessandra Luzzago and Monica Pezzanera and has published in prestigious journals such as Nature Medicine, Journal of Virology and Gene Therapy.

In The Last Decade

Mirko Arcuri

7 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirko Arcuri Italy 7 276 249 93 67 66 7 432
Ophélia Granio France 8 198 0.7× 170 0.7× 111 1.2× 85 1.3× 18 0.3× 9 348
Jimmy Mancip France 8 184 0.7× 176 0.7× 147 1.6× 61 0.9× 41 0.6× 8 388
Ton Kos Netherlands 9 191 0.7× 178 0.7× 63 0.7× 23 0.3× 134 2.0× 11 434
Ronda K. Sapp United States 7 480 1.7× 405 1.6× 75 0.8× 13 0.2× 82 1.2× 8 574
Allan G. N. Angus United Kingdom 11 438 1.6× 334 1.3× 123 1.3× 20 0.3× 54 0.8× 12 560
Nobuhiko Kamoshita Japan 10 169 0.6× 87 0.3× 239 2.6× 58 0.9× 26 0.4× 13 414
Maria Luisa Virata United States 6 272 1.0× 210 0.8× 80 0.9× 10 0.1× 35 0.5× 10 374
Kartik Trehan United States 5 332 1.2× 195 0.8× 154 1.7× 22 0.3× 45 0.7× 6 521
Lilin Zhong United States 12 248 0.9× 204 0.8× 171 1.8× 14 0.2× 40 0.6× 20 463
Huiming Hon United States 11 95 0.3× 143 0.6× 70 0.8× 29 0.4× 229 3.5× 11 391

Countries citing papers authored by Mirko Arcuri

Since Specialization
Citations

This map shows the geographic impact of Mirko Arcuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirko Arcuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirko Arcuri more than expected).

Fields of papers citing papers by Mirko Arcuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirko Arcuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirko Arcuri. The network helps show where Mirko Arcuri may publish in the future.

Co-authorship network of co-authors of Mirko Arcuri

This figure shows the co-authorship network connecting the top 25 collaborators of Mirko Arcuri. A scholar is included among the top collaborators of Mirko Arcuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirko Arcuri. Mirko Arcuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Fattori, Elena, Luigi Aurisicchio, Immacolata Zampaglione, et al.. (2009). ErbB2 Genetic Cancer Vaccine in Nonhuman Primates: Relevance of Single Nucleotide Polymorphisms. Human Gene Therapy. 20(3). 253–265. 14 indexed citations
2.
Arcuri, Mirko, Manuela Cappelletti, Immacolata Zampaglione, et al.. (2008). Synergistic effect of gene‐electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination. The Journal of Gene Medicine. 10(9). 1048–1054. 6 indexed citations
3.
Folgori, Antonella, Stefania Capone, Lionello Ruggeri, et al.. (2006). A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nature Medicine. 12(2). 190–197. 239 indexed citations
4.
Fattori, Elena, Immacolata Zampaglione, Mirko Arcuri, et al.. (2006). Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes. Gene Therapy. 13(14). 1088–1096. 36 indexed citations
5.
Zampaglione, Immacolata, Mirko Arcuri, Manuela Cappelletti, et al.. (2005). In vivo DNA gene electro-transfer: a systematic analysis of different electrical parameters. The Journal of Gene Medicine. 7(11). 1475–1481. 23 indexed citations
6.
Fattori, Elena, Manuela Cappelletti, Immacolata Zampaglione, et al.. (2005). Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates. The Journal of Gene Medicine. 7(2). 228–236. 49 indexed citations
7.
Barth, Heidi, Mirko Arcuri, Marco Hoffmann, et al.. (2005). Scavenger Receptor Class B Type I and Hepatitis C Virus Infection of PrimaryTupaiaHepatocytes. Journal of Virology. 79(9). 5774–5785. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026